Pomdoctor Ltd ADR POM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
POMDOCTOR LIMITED Highlights Healthcare Intelligence Flywheel as a Self-Reinforcing Growth Engine
-
POMDOCTOR LIMITED Highlights Four-Tier Diversified Revenue Structure
-
POMDOCTOR LIMITED Advances Healthcare Data Asset Strategy to Strengthen AI-Powered Chronic Disease Management Capabilities
-
POMDOCTOR LIMITED Regains Compliance with Nasdaq Bid Price Requirement
-
POMDOCTOR LIMITED Continues to Advance AI-Enabled Chronic Disease Management Strategy Amid Growing Demand for Predictive Healthcare
-
POMDOCTOR LIMITED Announces Strategic Upgrade Toward Infrastructure for Predictive Healthcare Data and Services
-
POMDOCTOR LIMITED Announces ADS Ratio Change to Be Effective on June 22, 2026
-
POMDOCTOR LIMITED Announces Plan to Implement ADS Ratio Change
Trading Information
- Previous Close Price
- $0.97
- Day Range
- $0.86–1.02
- 52-Week Range
- $0.50–115.74
- Bid/Ask
- $0.93 / $0.93
- Shares Outstanding
- 7.46M
- Market Cap
- $7.60M
- Volume/Avg
- 2,413 / 100,247
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.06
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of its revenue is derived from the Pharmaceutical supply chain segment.
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Stock Style Box
- —
- Total Number of Employees
- 165
- Website
- https://www.7lk.com
Valuation
|
Metric
|
POM
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.06 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
POM
|
|---|---|
Quick Ratio | 0.16 |
Current Ratio | 0.48 |
Interest Coverage | −9.16 |
Quick Ratio
POM
Profitability
|
Metric
|
POM
|
|---|---|
Return on Assets (Normalized) | −170.60% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
POM
Pharmaceutical Retailers Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| JD Health International Inc ADR
JDHIY
| — | LOCK|!#M$ | $16B | |||
| Alibaba Health Information Technology Ltd
ALBHF
| — | LOCK|hg>r | $7B | |||
| Alibaba Health Information Technology Ltd ADR
ALBBY
| — | LOCK|$@#YR | $7B | |||
| MatsukiyoCocokara & Co
MSMKF
| — | LOCK|!S | $6B | |||
| Raia Drogasil SA ADR
RADLY
| — | LOCK|Yc#br | $6B | |||
| Sugi Holdings Co Ltd
SGIPF
| — | LOCK|%# | $3B | |||
| COSMOS Pharmaceutical Corp
CSMYF
| — | LOCK|<n& | $3B | |||
| Clicks Group Ltd
CCKRF
| — | LOCK|ZDSv | $3B | |||
| Clicks Group Ltd ADR
CLCGY
| — | LOCK|<v&M | $3B | |||
| Redcare Pharmacy NV
SHPPF
| — | LOCK|^$b | $1B |
United States